חזרה לתוצאות החיפוש

Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

ישראלמגייס משתתפיםPHASE3

מצבים רפואיים

C3G

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Novartis Investigative Site, Petah Tikva, Israel

  • Novartis Investigative Site, Petah Tikva, Israel

  • Childrens Hospital Colorado, Aurora, Colorado, United States

    Contact: Study coordinator (Kati Dugan) · Kati.Dugan@childrenscolorado.org · +1 720 777 1234
    Contact: Principal Investigator (Bradley Dixon)

  • Nicklaus Childrens Hospital, Miami, Florida, United States

    Contact: Study coordinator (Jorge Haddad) · Jorge.Haddad@Nicklaushealth.org · +1 305 661 1515
    Contact: Principal Investigator (Ana Paredes)

  • Georgia Nephrology Research Inst, Lawrenceville, Georgia, United States

  • IN University School of Med, Indianapolis, Indiana, United States

  • University of Iowa Health Care, Iowa City, Iowa, United States

    Contact: Study coordinator (Nicole Gerot) · nicole-gerot@uiowa.edu · +1 319 335 7555
    Contact: Principal Investigator (Carla Nester)

  • University of Iowa Health Care, Iowa City, Iowa, United States

    Contact: Study coordinator (Nikki Gerot) · +1 (319) 335-0348
    Contact: Principal Investigator (Carla Nester)

  • Johns Hopkins Hospital, Baltimore, Maryland, United States

  • Brigham and Womens Hosp Harvard Med School, Boston, Massachusetts, United States

  • Hackensack Uni Medical Center, Hackensack, New Jersey, United States

  • Albany Medical Center, Albany, New York, United States

  • Col Uni Med Center New York Presby, New York, New York, United States

  • Baylor Scott and White Research, Temple, Texas, United States

  • University of Wisconsin, Madison, Wisconsin, United States

    Contact: Study coordinator (Alana Quackenbush) · akquackenbus@wisc.edu · +1 608 265 6020
    Contact: Principal Investigator (Sharon Bartosh)

  • Novartis Investigative Site, Córdoba, Córdoba Province, Argentina

  • Novartis Investigative Site, Buenos Aires, Argentina

  • Novartis Investigative Site, CABA, Argentina

  • Novartis Investigative Site, Edegem, Belgium

  • Novartis Investigative Site, Leuven, Belgium

  • Novartis Investigative Site, Belo Horizonte, Minas Gerais, Brazil

  • Novartis Investigative Site, Recife, Pernambuco, Brazil

  • Novartis Investigative Site, Passo Fundo, Rio Grande do Sul, Brazil

  • Novartis Investigative Site, Joinville, Santa Catarina, Brazil

  • Novartis Investigative Site, Santo André, São Paulo, Brazil

  • Novartis Investigative Site, São Paulo, São Paulo, Brazil

  • Novartis Investigative Site, São Paulo, São Paulo, Brazil

  • Novartis Investigative Site, Salvador, Brazil

  • Novartis Investigative Site, London, Ontario, Canada

  • Novartis Investigative Site, Toronto, Ontario, Canada

  • Novartis Investigative Site, Montreal, Quebec, Canada

  • Novartis Investigative Site, Guangzhou, Guangdong, China

  • Novartis Investigative Site, Wuhan, Hubei, China

  • Novartis Investigative Site, Beijing, China

  • Novartis Investigative Site, Beijing, China

  • Novartis Investigative Site, Shanghai, China

  • Novartis Investigative Site, Prague, Czechia

  • Novartis Investigative Site, Lille, France

  • Novartis Investigative Site, Marseille, France

  • Novartis Investigative Site, Montpellier, France

  • Novartis Investigative Site, Paris, France

  • Novartis Investigative Site, Paris, France

  • Novartis Investigative Site, Cologne, North Rhine-Westphalia, Germany

  • Novartis Investigative Site, Aachen, Germany

  • Novartis Investigative Site, Erlangen, Germany

  • Novartis Investigative Site, Essen, Germany

  • Novartis Investigative Site, Hamburg, Germany

  • Novartis Investigative Site, Hanover, Germany

  • Novartis Investigative Site, Heidelberg, Germany

  • Novartis Investigative Site, Mainz, Germany

  • Novartis Investigative Site, Athens, Greece

  • Novartis Investigative Site, Heraklion Crete., Greece

  • Novartis Investigative Site, Thessaloniki, Greece

  • Novartis Investigative Site, Thessaloniki, Greece

  • Novartis Investigative Site, New Delhi, National Capital Territory of Delhi, India

  • Novartis Investigative Site, New Delhi, National Capital Territory of Delhi, India

  • Novartis Investigative Site, Hyderabad, Telangana, India

  • Novartis Investigative Site, Lucknow, Uttar Pradesh, India

  • Novartis Investigative Site, Dehradun, Uttarakhand, India

  • Novartis Investigative Site, Ranica, BG, Italy

  • Novartis Investigative Site, Milan, MI, Italy

  • Novartis Investigative Site, Roma, RM, Italy

  • Novartis Investigative Site, Nagoya, Aichi-ken, Japan

  • Novartis Investigative Site, Asahikawa, Hokkaido, Japan

  • Novartis Investigative Site, Sapporo, Hokkaido, Japan

  • Novartis Investigative Site, Takatsuki, Osaka, Japan

  • Novartis Investigative Site, Ohtsu, Shiga, Japan

  • Novartis Investigative Site, Niigata, Japan

  • Novartis Investigative Site, Nijmegen, Gelderland, Netherlands

  • Novartis Investigative Site, Leiden, South Holland, Netherlands

  • Novartis Investigative Site, Barcelona, Catalonia, Spain

  • Novartis Investigative Site, Port de Sagunt, Valencia, Spain

  • Novartis Investigative Site, Barcelona, Spain

  • Novartis Investigative Site, Madrid, Spain

  • Novartis Investigative Site, Málaga, Spain

  • Novartis Investigative Site, Seville, Spain

  • Novartis Investigative Site, Bern, Switzerland

  • Novartis Investigative Site, Lausanne, Switzerland

  • Novartis Investigative Site, Istanbul, Fatih, Turkey (Türkiye)

  • Novartis Investigative Site, Istanbul, Fatih, Turkey (Türkiye)

  • Novartis Investigative Site, Kayseri, Melikgazi, Turkey (Türkiye)

  • Novartis Investigative Site, Ankara, Yenimahalle, Turkey (Türkiye)

  • Novartis Investigative Site, Ankara, Yenimahalle, Turkey (Türkiye)

  • Novartis Investigative Site, Glasgow, Scotland, United Kingdom

  • Novartis Investigative Site, Newcastle upon Tyne, Tyne and Wear, United Kingdom

  • Novartis Investigative Site, London, United Kingdom

  • Novartis Investigative Site, London, United Kingdom

מובילי המחקר

  • Novartis Pharmaceuticals

    Study Director

    Novartis Pharmaceuticals

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)